Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid vs Percutaneous Ablation in Osteoid Osteoma
NCT02739555Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in Osteoid osteoma (OO), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2016; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
Osteoid osteoma (OO)
Beyond the preview
Go deeper on NCT02739555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739555.